
The Eye Care Support Pathway
The Eye Care Support Pathway is a new framework to ensure patients have timely access to information, advice and support throughout their eye care journey.
Search results
The Eye Care Support Pathway is a new framework to ensure patients have timely access to information, advice and support throughout their eye care journey.
Several groups around the world are investigating the use of retinal transplantation in the treatment of inherited retinal diseases.
Research determines that taking high dose vitamin A supplements does not slow vision loss in people with retinitis pigmentosa (RP).
There are many ongoing clinical and laboratory studies around the world, exploring innovative approaches to treating inherited sight loss.
In February 2022, ProQR announced a disappointing outcome for their phase 2/3 trial of sepofarsen for Leber congenital amaurosis type 10 (LCA10).
The BBC World Service has undertaken an investigation of unproven treatments for retinitis pigmentosa (RP) and has produced a documentary film, called Blind Faith, which is available on BBC iPlayer.
Did you join either of our Conferences this year? You can read about them inside this edition of Look Forward. We’ve had some fantastic feedback from our delegates so if you weren’t able to attend, you can watch or listen to the recordings from the day on our website.
The Spring 2023 edition of the Retina UK newsletter, Look Forward, which includes articles about our upcoming events, research updates and more.
The cover of this edition celebrates the success of our amazing London Marathon team. Together they have raised more than £43,000.
It was previously believed that female carriers of X-linked inherited retinal diseases (IRDs) like X-linked retinitis pigmentosa (RP and Choroideremia) remained unaffected by sight loss.